Abstract
A multiple regression search analysis was conducted with 76 anxious outpatients treated in a 4 week clinical trial with either benzoctamine 60 mg/day or chlordiazepoxide 60 mg/day.
Better response was predicted:
For benzoctamine, in patients who are less educated, have an adequate occupational adjustment, and are initially higher in anxiety. For chlordiazepoxide, in patients who are more educated and have a marginal occupational adjustment. For both drugs, in patients who are black, are diagnosed as anxious rather than anxious-depressed, and are higher in initial depression. A major factor accounting for the differential effectiveness predicted for these 2 anti-anxiety agents was felt to be the large number of sedative side effects reported by patients receiving benzoctamine 60 mg/day.
Get full access to this article
View all access options for this article.